Several different pathophysiological mechanisms for POTS have been proposed, although these are poorly understood.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[4]Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020 Mar;36(3):357-72.
https://www.doi.org/10.1016/j.cjca.2019.12.024
http://www.ncbi.nlm.nih.gov/pubmed/32145864?tool=bestpractice.com
These mechanisms overlap and a patient may often have features of more than one mechanism.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[4]Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020 Mar;36(3):357-72.
https://www.doi.org/10.1016/j.cjca.2019.12.024
http://www.ncbi.nlm.nih.gov/pubmed/32145864?tool=bestpractice.com
Immune dysfunction
Immune dysfunction may play a role in POTS.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
Many patients with POTS report an infectious prodrome before the onset of orthostatic symptoms.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[11]Boris JR, Bernadzikowski T. Demographics of a large paediatric postural orthostatic tachycardia syndrome program. Cardiol Young. 2018 May;28(5):668-74.
http://www.ncbi.nlm.nih.gov/pubmed/29357955?tool=bestpractice.com
[13]Shaw BH, Stiles LE, Bourne K, et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019 Oct;286(4):438-48.
https://www.doi.org/10.1111/joim.12895
http://www.ncbi.nlm.nih.gov/pubmed/30861229?tool=bestpractice.com
In addition, patients with POTS and their close relatives have a higher prevalence of autoimmune disorders such as coeliac disease, Hashimoto’s thyroiditis, Sjogren syndrome, and systemic lupus erythematosus than the general population.[21]Penny HA, Aziz I, Ferrar M, et al. Is there a relationship between gluten sensitivity and postural tachycardia syndrome? Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1383-7.
http://www.ncbi.nlm.nih.gov/pubmed/27606948?tool=bestpractice.com
[22]Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015 Nov;24(13):1364-9.
http://www.ncbi.nlm.nih.gov/pubmed/26038344?tool=bestpractice.com
[23]Goodman BP, Crepeau A, Dhawan PS, et al. Spectrum of autonomic nervous system impairment in Sjögren syndrome. Neurologist. 2017 Jul;22(4):127-30.
http://www.ncbi.nlm.nih.gov/pubmed/28644253?tool=bestpractice.com
[24]Tang S, Calkins H, Petri M. Neurally mediated hypotension in systemic lupus erythematosus patients with fibromyalgia. Rheumatology (Oxford). 2004 May;43(5):609-14.
https://www.doi.org/10.1093/rheumatology/keh132
http://www.ncbi.nlm.nih.gov/pubmed/14983104?tool=bestpractice.com
A few studies have reported that some patients with POTS have elevated levels of autoantibodies, which act as partial agonists to alpha- and beta-adrenergic receptors.[25]Fedorowski A, Li H, Yu X, et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017 Jul 1;19(7):1211-9.
https://www.doi.org/10.1093/europace/euw154
http://www.ncbi.nlm.nih.gov/pubmed/27702852?tool=bestpractice.com
[26]Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014 Feb 26;3(1):e000755.
https://www.doi.org/10.1161/JAHA.113.000755
http://www.ncbi.nlm.nih.gov/pubmed/24572257?tool=bestpractice.com
[27]Vernino S, Stiles LE. Autoimmunity in postural orthostatic tachycardia syndrome: current understanding. Auton Neurosci. 2018 Dec;215:78-82.
https://www.doi.org/10.1016/j.autneu.2018.04.005
http://www.ncbi.nlm.nih.gov/pubmed/29909990?tool=bestpractice.com
This may cause the typical postural and cardiovascular features seen in POTS.[28]Li H, Zhang G, Zhou L, et al. Adrenergic autoantibody-induced postural tachycardia syndrome in rabbits. J Am Heart Assoc. 2019 Oct;8(19):e013006.
https://www.doi.org/10.1161/JAHA.119.013006
http://www.ncbi.nlm.nih.gov/pubmed/31547749?tool=bestpractice.com
Despite these findings, a definite link between autoantibodies and POTS has not been established.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
Abnormal cardiovascular physiology
Some 70% of patients with POTS have absolute hypovolaemia, with low plasma and red blood cell volume.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[2]Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.
https://www.doi.org/10.1016/j.hrthm.2015.03.029
http://www.ncbi.nlm.nih.gov/pubmed/25980576?tool=bestpractice.com
[4]Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020 Mar;36(3):357-72.
https://www.doi.org/10.1016/j.cjca.2019.12.024
http://www.ncbi.nlm.nih.gov/pubmed/32145864?tool=bestpractice.com
[5]Fu Q, Vangundy TB, Galbreath MM, et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2010 Jun 22;55(25):2858-68.
https://www.doi.org/10.1016/j.jacc.2010.02.043
http://www.ncbi.nlm.nih.gov/pubmed/20579544?tool=bestpractice.com
[6]Raj SR, Biaggioni I, Yamhure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2005 Apr 5;111(13):1574-82.
https://www.doi.org/10.1161/01.CIR.0000160356.97313.5D
http://www.ncbi.nlm.nih.gov/pubmed/15781744?tool=bestpractice.com
Hypovolaemia in POTS is due to impaired regulation of plasma volume, which occurs as a result of reduced ability of the renin-angiotensin-aldosterone system to expand the blood volume.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[2]Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.
https://www.doi.org/10.1016/j.hrthm.2015.03.029
http://www.ncbi.nlm.nih.gov/pubmed/25980576?tool=bestpractice.com
[6]Raj SR, Biaggioni I, Yamhure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2005 Apr 5;111(13):1574-82.
https://www.doi.org/10.1161/01.CIR.0000160356.97313.5D
http://www.ncbi.nlm.nih.gov/pubmed/15781744?tool=bestpractice.com
[29]Li J, Liao Y, Du J, et al. [Relationship between 24-hour urinary sodium and renin-angiotensin-aldosterone system in children with postural tachycardia syndrome]. [in chi]. Zhonghua Yi Xue Za Zhi. 2015 Sep 22;95(36):2928-32.
http://www.ncbi.nlm.nih.gov/pubmed/26814068?tool=bestpractice.com
[30]Mustafa HI, Garland EM, Biaggioni I, et al. Abnormalities of angiotensin regulation in postural tachycardia syndrome. Heart Rhythm. 2011 Mar;8(3):422-8.
http://www.ncbi.nlm.nih.gov/pubmed/21266211?tool=bestpractice.com
[31]Stewart JM, Medow MS, Glover JL, et al. Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H665-73.
https://www.doi.org/10.1152/ajpheart.00784.2005
http://www.ncbi.nlm.nih.gov/pubmed/16143646?tool=bestpractice.com
Hypovolaemia causes reduced systemic venous return and reduced cardiac output, with subsequent reflex tachycardia and orthostatic intolerance.[6]Raj SR, Biaggioni I, Yamhure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2005 Apr 5;111(13):1574-82.
https://www.doi.org/10.1161/01.CIR.0000160356.97313.5D
http://www.ncbi.nlm.nih.gov/pubmed/15781744?tool=bestpractice.com
[7]Jacob G, Biaggioni I, Mosqueda-Garcia R, et al. Relation of blood volume and blood pressure in orthostatic intolerance. Am J Med Sci. 1998 Feb;315(2):95-100.
http://www.ncbi.nlm.nih.gov/pubmed/9472908?tool=bestpractice.com
Many patients with POTS also have reduced left ventricular mass, low stroke volume, and impaired cardiac filling due to cardiovascular deconditioning, which can further contribute to hypovolaemia and symptoms of POTS.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[2]Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.
https://www.doi.org/10.1016/j.hrthm.2015.03.029
http://www.ncbi.nlm.nih.gov/pubmed/25980576?tool=bestpractice.com
However, it is unclear whether cardiovascular deconditioning is a primary cause of POTS, or caused by avoidance of exercise due to orthostatic symptoms.[2]Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.
https://www.doi.org/10.1016/j.hrthm.2015.03.029
http://www.ncbi.nlm.nih.gov/pubmed/25980576?tool=bestpractice.com
Excessive sympathetic activation
Patients with hyperadrenergic POTS may have abnormally increased sympathetic activity and circulating catecholamine excess.[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[2]Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.
https://www.doi.org/10.1016/j.hrthm.2015.03.029
http://www.ncbi.nlm.nih.gov/pubmed/25980576?tool=bestpractice.com
Peripheral autonomic dysfunction
Many patients with POTS have peripheral autonomic denervation, which leads to venous pooling, relative central hypovolaemia, and low blood volume (absolute hypovolaemia).[1]Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health expert consensus meeting - part 1. Auton Neurosci. 2021 Nov;235:102828.
https://www.doi.org/10.1016/j.autneu.2021.102828
http://www.ncbi.nlm.nih.gov/pubmed/34144933?tool=bestpractice.com
[2]Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63.
https://www.doi.org/10.1016/j.hrthm.2015.03.029
http://www.ncbi.nlm.nih.gov/pubmed/25980576?tool=bestpractice.com
[4]Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020 Mar;36(3):357-72.
https://www.doi.org/10.1016/j.cjca.2019.12.024
http://www.ncbi.nlm.nih.gov/pubmed/32145864?tool=bestpractice.com
This is particularly seen with neuropathic POTS.